Elevance Health Net Income Over Time
| ELV Stock | USD 341.83 3.91 1.13% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Elevance Health Performance and Elevance Health Correlation. What growth prospects exist in Health Care Providers & Services sector? Can Elevance capture new markets? Factors like these will boost the valuation of Elevance Health. Projected growth potential of Elevance fundamentally drives upward valuation adjustments. Valuation analysis balances hard financial data with qualitative growth assessments. While each Elevance Health valuation metric matters, prioritizing which indicators carry greater predictive weight remains essential.
Quarterly Earnings Growth 0.363 | Dividend Share 6.84 | Earnings Share 25.14 | Revenue Per Share | Quarterly Revenue Growth 0.095 |
The market value of Elevance Health is measured differently than its book value, which is the value of Elevance that is recorded on the company's balance sheet. Investors also form their own opinion of Elevance Health's value that differs from its market value or its book value, called intrinsic value, which is Elevance Health's true underlying value. Investment professionals apply varied valuation frameworks to compute inherent worth and acquire positions when market prices trade at discounts to calculated value. Because Elevance Health's market value can be influenced by many factors that don't directly affect Elevance Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Elevance Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Elevance Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Elevance Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Cross Equities Net Income Analysis
Compare Elevance Health and related stocks such as Cigna Corp, Regeneron Pharmaceuticals, and Cencora Net Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CI | (854.6 M) | 1.3 B | 1.6 B | 1.5 B | 2.1 B | 2.1 B | 1.9 B | 2.2 B | 2.6 B | 5.1 B | 8.5 B | 5.4 B | 6.7 B | 5.2 B | 3.4 B | 3.9 B | 4.1 B |
| REGN | (3.3 M) | (221.8 M) | 750.3 M | 424.4 M | 348.1 M | 636.1 M | 895.5 M | 1.2 B | 2.4 B | 2.1 B | 3.5 B | 8.1 B | 4.3 B | 4 B | 4.4 B | 4.5 B | 4.7 B |
| COR | (207.7 M) | 719 M | 433.7 M | 276.5 M | (134.9 M) | 1.4 B | 414.5 M | 1.7 B | 855.4 M | (3.4 B) | 1.5 B | 1.7 B | 1.7 B | 1.5 B | 1.6 B | 1.8 B | 1.9 B |
| ZTS | (100 M) | 245 M | 436 M | 504 M | 583 M | 339 M | 821 M | 864 M | 1.4 B | 1.5 B | 1.6 B | 2 B | 2.1 B | 2.3 B | 2.5 B | 2.9 B | 3 B |
| IDXX | 3.2 M | 161.8 M | 178.3 M | 187.8 M | 181.9 M | 192.1 M | 222 M | 263.1 M | 377 M | 427.7 M | 581.8 M | 744.8 M | 679.1 M | 845 M | 887.9 M | 1.1 B | 1.1 B |
| CVS | 210.2 M | 3.5 B | 3.9 B | 4.6 B | 4.6 B | 5.2 B | 5.3 B | 6.6 B | (594 M) | 6.6 B | 7.2 B | 8 B | 4.3 B | 8.3 B | 4.6 B | 5.3 B | 5.6 B |
| GSK | 400 M | 5.3 B | 4.5 B | 5.4 B | 2.8 B | 8.4 B | 912 M | 1.5 B | 3.6 B | 4.6 B | 5.7 B | 4.4 B | 15 B | 4.9 B | 2.6 B | 3 B | 3.7 B |
| BDX | 88 M | 1.2 B | 1.3 B | 1.2 B | 695 M | 976 M | 1.1 B | 311 M | 1.2 B | 874 M | 2.1 B | 1.8 B | 1.5 B | 1.7 B | 1.7 B | 1.9 B | 2 B |
| GEHC | 1.5 B | 1.5 B | 1.5 B | 1.5 B | 1.5 B | 1.5 B | 1.5 B | 1.5 B | 1.5 B | 1.5 B | 13.8 B | 2.2 B | 1.9 B | 3.1 B | 2 B | 1.8 B | 3.3 B |
Elevance Health and related stocks such as Cigna Corp, Regeneron Pharmaceuticals, and Cencora Net Income description
Net income is one of the most important fundamental items in finance. It plays a large role in Elevance Health financial statement analysis. It represents the amount of money remaining after all of Elevance Health operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue.My Equities
My Current Equities and Potential Positions
| Elevance Health | ELV |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 220 Virginia Avenue, |
| Exchange | New York Stock Exchange |
USD 341.83
Additional Tools for Elevance Stock Analysis
When running Elevance Health's price analysis, check to measure Elevance Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elevance Health is operating at the current time. Most of Elevance Health's value examination focuses on studying past and present price action to predict the probability of Elevance Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elevance Health's price. Additionally, you may evaluate how the addition of Elevance Health to your portfolios can decrease your overall portfolio volatility.